New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 21, 2012
09:47 EDTMDGNMedgenics granted U.S. patent for use of Epodure technology for EPO delivery
Medgenics announced a patent granted by the U.S. Patent and Trademark Office protecting the use of Medgenics’ Epodure Biopump technology for delivery of erythropoietin, or EPO. Medgenics is developing Epodure to address the need for safer, sustained treatment of anemia. The USPTO also allowed claims covering a similar method for delivery of clotting Factor VIII, underlying Medgenics’ Hemodure Biopump technology for sustained prophylactic treatment of hemophilia.
News For MDGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 8, 2014
10:00 EDTMDGNOn The Fly: Analyst Initiation Summary
Subscribe for More Information
05:45 EDTMDGNMedgenics initiated with an Overweight at Piper Jaffray
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use